Lihong Liu

Active 2007–2026

258
Papers
24,742
Citations
73
h-index
210
i10-index

Citations

Citations per year for Lihong Liu1982: 1 citations1984: 1 citations1991: 1 citations1993: 1 citations2000: 1 citations2002: 1 citations2003: 1 citations2004: 1 citations2005: 1 citations2008: 1 citations2009: 18 citations2010: 29 citations2011: 37 citations2012: 42 citations2013: 71 citations2014: 63 citations2015: 75 citations2016: 71 citations2017: 75 citations2018: 116 citations2019: 311 citations2020: 651 citations2021: 1,684 citations2022: 1,476 citations2023: 1,076 citations2024: 1,642 citations2025: 779 citations2026: 46 citations1983: no citations, so this year is not shown1985–1990: no citations, so these years are not shown1992: no citations, so this year is not shown1994–1999: no citations, so these years are not shown2001: no citations, so this year is not shown2006–2007: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 2,606 citing papers, 23.8% of this breakdownUnited States: 1,972 citing papers, 18% of this breakdownUnited Kingdom: 539 citing papers, 4.9% of this breakdownIndia: 532 citing papers, 4.8% of this breakdownGermany: 357 citing papers, 3.3% of this breakdownItaly: 303 citing papers, 2.8% of this breakdownCanada: 255 citing papers, 2.3% of this breakdownAustralia: 240 citing papers, 2.2% of this breakdownFrance: 223 citing papers, 2% of this breakdownIran: 213 citing papers, 1.9% of this breakdownSouth Korea: 209 citing papers, 1.9% of this breakdownSpain: 182 citing papers, 1.7% of this breakdown
0%23.8%Other 30.4%

Fields

  • Medicine51.5%
  • Biochemistry, Genetics and Molecular Biology17.5%
  • Materials Science7.1%
  • Engineering6.1%
  • Immunology and Microbiology4.3%
  • Agricultural and Biological Sciences3.7%
  • Other9.8%

Topics

  • SARS-CoV-2 and COVID-19 Research11%
  • COVID-19 Clinical Research Studies5%
  • Nanoparticle-Based Drug Delivery2.3%
  • SARS-CoV-2 detection and testing2.3%
  • vaccines and immunoinformatics approaches2.2%
  • Animal Virus Infections Studies2%
  • Other75.2%

Coauthors

All papers

Open in search
  1. Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance

    Authors: , , , , , , , , , - Frontiers in Molecular Biosciences 2020 cited by 1,492

  2. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants

    Authors: , , , , , , , , , , , , , , , , - Cell 2022 cited by 946

  3. IDRiD: Diabetic Retinopathy - Segmentation and Grading Challenge

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Varghese Alex, Xingzheng Lyu, Li Cheng, Qinhao Chu, Pengcheng Li, Xin Ji, Sanyuan Zhang, Yaxin Shen, Ling Dai, Oindrila Saha, Rachana Sathish, Tânia Melo, Teresa Araújo, Balázs Harangi, Bin Sheng, Ruogu Fang, Debdoot Sheet, András Hajdú, Yuanjie Zheng, Ana Maria Mendonc̨a, Shaoting Zhang, Aurélio Campilho, Bin Zheng, Dinggang Shen, Luca Giancardo, Gwenolé Quellec, Fabrice Mériaudeau - Medical Image Analysis, Medical Image Anal. 2019 cited by 356

  4. Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spike

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature 2023 cited by 206

  5. Modern methods for delivery of drugs across the blood–brain barrier

    Authors: , - Advanced Drug Delivery Reviews 2011 cited by 984

  6. Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature 2020 cited by 1,619

  7. XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN.1

    Authors: , , , , , , , , - Cell Host & Microbe 2024 cited by 177

  8. A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spike

    Authors: , , , , , , , , , , , , , - Cell 2023 cited by 214

  9. Antibody evasion properties of SARS-CoV-2 Omicron sublineages

    Authors: , , , , , , , , , , , , , , , , , , - Nature 2022 cited by 861

  10. Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Cell Host & Microbe 2021 cited by 587

  11. Deep Learning Methods for Lung Cancer Segmentation in Whole-Slide Histopathology Images - The ACDC@LungHP Challenge 2019

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hui Chen, Yuling Tang, Geert Litjens - IEEE Journal of Biomedical and Health Informatics, IEEE J. Biomed. Health Informatics 2020 cited by 152

  12. Antibody Response to Omicron BA.4–BA.5 Bivalent Booster

    Authors: , , , , , , - New England Journal of Medicine 2023 cited by 211

  13. Antibody neutralisation of emerging SARS-CoV-2 subvariants: EG.5.1 and XBC.1.6

    Authors: , , , , , , , , , - The Lancet Infectious Diseases 2023 cited by 89

  14. Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent

    Authors: , , , , , , , - Nature Nanotechnology 2009 cited by 667

  15. Parthanatos and its associated components: Promising therapeutic targets for cancer

    Authors: , , , , , , , - Pharmacological Research 2020 cited by 135

  16. Multivariable Finite Time Attitude Control for Quadrotor UAV: Theory and Experimentation

    Authors: , , , , , - IEEE Transactions on Industrial Electronics, IEEE Trans. Ind. Electron. 2017 cited by 292

  17. Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Qingshu Zeng, Zhihui Zhang, Zhen Cai, Xiequn Chen, Kaiyang Ding, Ming Hou, Huiqiang Huang, Xiaoling Li, Rong Liang, Qifa Liu, Yuqin Song, Hang Su, Yuhuan Gao, Lihong Liu, Jian‐Min Luo, Liping Su, Zimin Sun, Huo Tan, Huaqing Wang, Jingwen Wang, Shuye Wang, Hongyu Zhang, Xiaohong Zhang, Daobin Zhou, Ou Bai, Gang Wu, Liling Zhang, Yizhuo Zhang - Journal of Hematology & Oncology 2017 cited by 256

  18. Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2021 cited by 454

  19. XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against emerging SARS-CoV-2 variants

    Authors: , , , , , , , , - 2023 cited by 43

  20. Regulation of Carotenoid Metabolism in Tomato

    Authors: , , , - Molecular Plant 2015 cited by 365

  21. Aptamer-Based Lateral Flow Test Strip for Rapid Detection of Zearalenone in Corn Samples

    Authors: , , , , , - Journal of Agricultural and Food Chemistry 2018 cited by 203

  22. Antibacterial mechanism of silver nanoparticles in Pseudomonas aeruginosa: proteomics approach

    Authors: , , , , , , - Metallomics 2018 cited by 296

  23. Attitude Control of UAVs Based on Event-Triggered Supertwisting Algorithm

    Authors: , , , , - IEEE Transactions on Industrial Informatics, IEEE Trans. Ind. Informatics 2020 cited by 83

  24. Recurrent SARS-CoV-2 spike mutations confer growth advantages to select JN.1 sublineages

    Authors: , , , , , , , , , , , , , - Emerging Microbes & Infections 2024 cited by 57